Luke S. Chang
277 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Corrigendum to "RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer" [Cellular Signaling, 48 (2018) 38-44].
Journal: Cellular signalling
Published: July 20, 2026
MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling.
Journal: Cellular signalling
Published: February 03, 2021
Editor's Note: PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway.
Journal: Cancer research
Published: December 04, 2019
Correction: Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Journal: Oncotarget
Published: June 25, 2019
Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.
Journal: Molecular oncology
Published: March 02, 2018
The expression and function of RASAL2 in renal cell carcinoma angiogenesis.
Journal: Cell death & disease
Published: February 02, 2018
RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
Journal: Cellular signalling
Published: January 09, 2018
Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Journal: Oncology reports
Published: December 15, 2017
Correction: Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.
Journal: Oncotarget
Published: January 14, 2017
FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 30, 2015
Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
Journal: Oncotarget
Published: June 25, 2015
Last Updated: 09/26/2026